IMMU-11. BRAINCHILD PIPELINE: LOCOREGIONAL IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RECURRENT/REFRACTORY CENTRAL NERVOUS SYSTEM TUMORS
Nicholas A. Vitanza(Seattle Children's Hospital), Michael C. Jensen(Seattle Children's Hospital), Catherine Lindgren(Unknown), Nicole A. P. Lieberman(University of Washington Medical Center), Jason S. Hauptman(Seattle Children's Hospital), Courtney A. Crane(APT Therapeutics (United States)), Julie Park(University of California, Los Angeles), Sarah Leary(Seattle Children's Hospital), Md. Zahid Hossain, Jeffrey G. Ojemann(Seattle Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Robert H. Pierce(Mabvax Therapeutics (United States)), Navin Pinto(Seattle Children's Hospital), Olivia Finney(Seattle Children's Hospital), Amy Lee(Royal Hobart Hospital), Adam Johnson(Sana Biotechnology (United States)), Laura S. Finn(Seattle Children's Hospital), Leslie Elliott(Seattle Children's Hospital), Juliane Gust(University of Washington)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k